Among the antiproliferative drugs, paclitaxel and everolimus were chosen because they have been used in DES and have different mechanisms of action: paclitaxel stabilizes microtubules, and everolimus inhibits mTOR.[4] Because drugs coated on DCBs or DESs are released immediately after the surgery, they were administered simultaneously with the cytokines used in the IH condition. The gene discussed is MTOR; the disease is isolated hemihyperplasia.